Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Fritzsche

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Deutsche Medizinische Wochenschrift (1946)|January 23, 2016
[32-year-old patient with growing oral finding]Benjamin T Schleenvoigt, Micha Löbermann, Carlos Fritzsche, et al.
Case Reports in Gastrointestinal Medicine|November 17, 2025
Drug-Induced Liver Failure Following Topical Minoxidil: A Case ReportKatrin Premke, Matthias Kästner, Carlos Fritzsche, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Diarrhea caused by primarily non-gastrointestinal infectionsEmil C Reisinger, Carlos Fritzsche, Robert Krause, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2006
Pneumocystis jiroveci dihydropteroate synthase gene mutations at codon 171 but not at codons 55 or 57 detected in GermanyDiana Riebold, Carlos Fritzsche, Matthias Lademann, et al.
Vaccine|March 21, 2019
Immune response to hepatitis A vaccine in patients with HIVCarlos Fritzsche, Lisa Bergmann, Micha Loebermann, et al.
Emerging Infectious Diseases|November 4, 2006
Borrelia burgdorferi and Anaplasma phagocytophilum coinfectionMicha Loebermann, Volker Fingerle, Matthias Lademann, et al.
Infectious Diseases (London, England)|September 30, 2016
High Pneumocystis jirovecii colonization rate among haemodialysis patientsCarlos Fritzsche, Hosam Ghanem, Sebastian Koball, et al.
Human Vaccines & Immunotherapeutics|August 18, 2018
Bilateral deafness two days following influenza vaccination: a case reportClaudia Kolarov, Micha Löbermann, Carlos Fritzsche, et al.
Autoimmunity Reviews|May 31, 2011
Immunization in the adult immunocompromised hostMicha Löbermann, Denise Boršo, Inken Hilgendorf, et al.
Infection|October 10, 2018
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adultsMicha Loebermann, Carlos Fritzsche, Hilte Geerdes-Fenge, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Deutsche Medizinische Wochenschrift (1946)|January 23, 2016
[32-year-old patient with growing oral finding]Benjamin T Schleenvoigt, Micha Löbermann, Carlos Fritzsche, et al.
Case Reports in Gastrointestinal Medicine|November 17, 2025
Drug-Induced Liver Failure Following Topical Minoxidil: A Case ReportKatrin Premke, Matthias Kästner, Carlos Fritzsche, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Diarrhea caused by primarily non-gastrointestinal infectionsEmil C Reisinger, Carlos Fritzsche, Robert Krause, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2006
Pneumocystis jiroveci dihydropteroate synthase gene mutations at codon 171 but not at codons 55 or 57 detected in GermanyDiana Riebold, Carlos Fritzsche, Matthias Lademann, et al.
Vaccine|March 21, 2019
Immune response to hepatitis A vaccine in patients with HIVCarlos Fritzsche, Lisa Bergmann, Micha Loebermann, et al.
Emerging Infectious Diseases|November 4, 2006
Borrelia burgdorferi and Anaplasma phagocytophilum coinfectionMicha Loebermann, Volker Fingerle, Matthias Lademann, et al.
Infectious Diseases (London, England)|September 30, 2016
High Pneumocystis jirovecii colonization rate among haemodialysis patientsCarlos Fritzsche, Hosam Ghanem, Sebastian Koball, et al.
Human Vaccines & Immunotherapeutics|August 18, 2018
Bilateral deafness two days following influenza vaccination: a case reportClaudia Kolarov, Micha Löbermann, Carlos Fritzsche, et al.
Autoimmunity Reviews|May 31, 2011
Immunization in the adult immunocompromised hostMicha Löbermann, Denise Boršo, Inken Hilgendorf, et al.
Infection|October 10, 2018
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adultsMicha Loebermann, Carlos Fritzsche, Hilte Geerdes-Fenge, et al.
Pageof 4